Cargando…

The Ontology of Vaccine Adverse Events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines

BACKGROUND: Licensed human vaccines can induce various adverse events (AE) in vaccinated patients. Due to the involvement of the whole immune system and complex immunological reactions after vaccination, it is difficult to identify the relations among vaccines, adverse events, and human populations...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcos, Erica, Zhao, Bin, He, Yongqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177204/
https://www.ncbi.nlm.nih.gov/pubmed/24279920
http://dx.doi.org/10.1186/2041-1480-4-40
_version_ 1782336742562463744
author Marcos, Erica
Zhao, Bin
He, Yongqun
author_facet Marcos, Erica
Zhao, Bin
He, Yongqun
author_sort Marcos, Erica
collection PubMed
description BACKGROUND: Licensed human vaccines can induce various adverse events (AE) in vaccinated patients. Due to the involvement of the whole immune system and complex immunological reactions after vaccination, it is difficult to identify the relations among vaccines, adverse events, and human populations in different age groups. Many known vaccine adverse events (VAEs) have been recorded in the package inserts of US-licensed commercial vaccine products. To better represent and analyze VAEs, we developed the Ontology of Vaccine Adverse Events (OVAE) as an extension of the Ontology of Adverse Events (OAE) and the Vaccine Ontology (VO). RESULTS: Like OAE and VO, OVAE is aligned with the Basic Formal Ontology (BFO). The commercial vaccines and adverse events in OVAE are imported from VO and OAE, respectively. A new population term ‘human vaccinee population’ is generated and used to define VAE occurrence. An OVAE design pattern is developed to link vaccine, adverse event, vaccinee population, age range, and VAE occurrence. OVAE has been used to represent and classify the adverse events recorded in package insert documents of commercial vaccines licensed by the USA Food and Drug Administration (FDA). OVAE currently includes over 1,300 terms, including 87 distinct types of VAEs associated with 63 human vaccines licensed in the USA. For each vaccine, occurrence rates for every VAE in different age groups have been logically represented in OVAE. SPARQL scripts were developed to query and analyze the OVAE knowledge base data. To demonstrate the usage of OVAE, the top 10 vaccines accompanying with the highest numbers of VAEs and the top 10 VAEs most frequently observed among vaccines were identified and analyzed. Asserted and inferred ontology hierarchies classify VAEs in different levels of AE groups. Different VAE occurrences in different age groups were also analyzed. CONCLUSIONS: The ontology-based data representation and integration using the FDA-approved information from the vaccine package insert documents enables the identification of adverse events from vaccination in relation to predefined parts of the population (age groups) and certain groups of vaccines. The resulting ontology-based VAE knowledge base classifies vaccine-specific VAEs and supports better VAE understanding and future rational AE prevention and treatment.
format Online
Article
Text
id pubmed-4177204
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41772042014-09-28 The Ontology of Vaccine Adverse Events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines Marcos, Erica Zhao, Bin He, Yongqun J Biomed Semantics Research BACKGROUND: Licensed human vaccines can induce various adverse events (AE) in vaccinated patients. Due to the involvement of the whole immune system and complex immunological reactions after vaccination, it is difficult to identify the relations among vaccines, adverse events, and human populations in different age groups. Many known vaccine adverse events (VAEs) have been recorded in the package inserts of US-licensed commercial vaccine products. To better represent and analyze VAEs, we developed the Ontology of Vaccine Adverse Events (OVAE) as an extension of the Ontology of Adverse Events (OAE) and the Vaccine Ontology (VO). RESULTS: Like OAE and VO, OVAE is aligned with the Basic Formal Ontology (BFO). The commercial vaccines and adverse events in OVAE are imported from VO and OAE, respectively. A new population term ‘human vaccinee population’ is generated and used to define VAE occurrence. An OVAE design pattern is developed to link vaccine, adverse event, vaccinee population, age range, and VAE occurrence. OVAE has been used to represent and classify the adverse events recorded in package insert documents of commercial vaccines licensed by the USA Food and Drug Administration (FDA). OVAE currently includes over 1,300 terms, including 87 distinct types of VAEs associated with 63 human vaccines licensed in the USA. For each vaccine, occurrence rates for every VAE in different age groups have been logically represented in OVAE. SPARQL scripts were developed to query and analyze the OVAE knowledge base data. To demonstrate the usage of OVAE, the top 10 vaccines accompanying with the highest numbers of VAEs and the top 10 VAEs most frequently observed among vaccines were identified and analyzed. Asserted and inferred ontology hierarchies classify VAEs in different levels of AE groups. Different VAE occurrences in different age groups were also analyzed. CONCLUSIONS: The ontology-based data representation and integration using the FDA-approved information from the vaccine package insert documents enables the identification of adverse events from vaccination in relation to predefined parts of the population (age groups) and certain groups of vaccines. The resulting ontology-based VAE knowledge base classifies vaccine-specific VAEs and supports better VAE understanding and future rational AE prevention and treatment. BioMed Central 2013-11-26 /pmc/articles/PMC4177204/ /pubmed/24279920 http://dx.doi.org/10.1186/2041-1480-4-40 Text en Copyright © 2013 Marcos et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Marcos, Erica
Zhao, Bin
He, Yongqun
The Ontology of Vaccine Adverse Events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines
title The Ontology of Vaccine Adverse Events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines
title_full The Ontology of Vaccine Adverse Events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines
title_fullStr The Ontology of Vaccine Adverse Events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines
title_full_unstemmed The Ontology of Vaccine Adverse Events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines
title_short The Ontology of Vaccine Adverse Events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines
title_sort ontology of vaccine adverse events (ovae) and its usage in representing and analyzing adverse events associated with us-licensed human vaccines
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177204/
https://www.ncbi.nlm.nih.gov/pubmed/24279920
http://dx.doi.org/10.1186/2041-1480-4-40
work_keys_str_mv AT marcoserica theontologyofvaccineadverseeventsovaeanditsusageinrepresentingandanalyzingadverseeventsassociatedwithuslicensedhumanvaccines
AT zhaobin theontologyofvaccineadverseeventsovaeanditsusageinrepresentingandanalyzingadverseeventsassociatedwithuslicensedhumanvaccines
AT heyongqun theontologyofvaccineadverseeventsovaeanditsusageinrepresentingandanalyzingadverseeventsassociatedwithuslicensedhumanvaccines
AT marcoserica ontologyofvaccineadverseeventsovaeanditsusageinrepresentingandanalyzingadverseeventsassociatedwithuslicensedhumanvaccines
AT zhaobin ontologyofvaccineadverseeventsovaeanditsusageinrepresentingandanalyzingadverseeventsassociatedwithuslicensedhumanvaccines
AT heyongqun ontologyofvaccineadverseeventsovaeanditsusageinrepresentingandanalyzingadverseeventsassociatedwithuslicensedhumanvaccines